Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

< Back to Results

Alert icon

This dataset is available to Authorized Users of the Project Data Sphere Cancer Research Platform through an initiative with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH). To gain access to this dataset, you must complete the following steps:

  1. Add the dataset to your request by clicking 'Add to Request' button below. You may add dataset(s) with up to 5 clinical trials in a single request.
  2. After adding all desired datasets to your request, you must complete a request form accessible via the 'My Data Requests' link in your account profile. After submitting your data request form, your request will be delivered to NCI for approval.
  3. Once your request is approved, you will receive notice that you have access to the dataset(s) in SAS® Life Sciences Analytic Framework within the Project Data Sphere Cancer Research Platform and that you may download the dataset(s) onto a personal machine.

To be able to request access to this data and the other analytic tools click here.

Breast

A Randomized Phase III Trial of Sequential Chemotherapy Using Doxorubicin, Paclitaxel, and Cyclophosphamide or Concurrent Doxorubicin and Cyclophosphamide Followed by Paclitaxel at 14 or 21 Day Intervals in Women With Node Positive Stage II/IIIA Breast Cancer

Unique Dataset IDnci-data-363ClinicalTrial.gov IDNCT00003088
DownloadableNo
SponsorAlliance for Clinical Trials in OncologyData ProviderNational Cancer InstituteTotal Study Enrolled Patients1973RandomizationYesPubMed (PMID)12668651.0
Study PhaseClinical Study Phase IIIBlinding MethodOpen Label StudyType(s) of dataN/AIntervention TypeDrugDataset TypeOther

Clinical Trial Title

A Randomized Phase III Trial of Sequential Chemotherapy Using Doxorubicin, Paclitaxel, and Cyclophosphamide or Concurrent Doxorubicin and Cyclophosphamide Followed by Paclitaxel at 14 or 21 Day Intervals in Women With Node Positive Stage II/IIIA Breast Cancer

Trial Summary and Conditions

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs at different times or combining more than one drug may kill more tumor cells. It is not yet known which chemotherapy regimen is more effective for breast cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy consisting of either doxorubicin, cyclophosphamide, or paclitaxel given at different times with that of combination chemotherapy consisting of doxorubicin plus cyclophosphamide followed by paclitaxel in treating women with stage II or stage IIIA breast cancer.

Data Summary

See data dictionary for more details.

Study Objectives

OBJECTIVES: I. Compare the sequential chemotherapy with doxorubicin, paclitaxel and cyclophosphamide to combined doxorubicin and cyclophosphamide followed by paclitaxel for disease free and overall survival in women with node positive stage II or IIIA breast cancer. II. Determine whether increasing the dose density of adjuvant chemotherapy will improve disease free and overall survival. III. Compare the toxicity in patients treated with these regimens. OUTLINE: This is a randomized study. Patients are randomized into one of four arms (sequential chemotherapy every 2 weeks vs every 3 weeks vs concurrent chemotherapy followed by paclitaxel every 2 weeks vs every 3 weeks). All tumor should be removed by either a modified radical mastectomy or a segmental mastectomy plus axillary node dissection. Adjuvant chemotherapy is started within 84 days following the last surgical procedure. See https://clinicaltrials.gov/ct2/show/NCT00003088 for more details.

Outcome Measures

Disease free survival [ Time Frame: 4 years ]

ClinicalTrial.gov

Below are the clinical trial(s) associated with this dataset (all links are to ClinicalTrials.Gov):

NCI Description

The NCT00003088_D10_(treated) dataset is one of 5 datasets associated with PubMed ID 12668651. This dataset contains one record for treated patients only (N=1973). The dataset contains the primary and secondary endpoint survival data. Dataset NCT00003088-D5 and NCT00003088-D10 each contain the same clinical data. NCT00003088-D10 also contains a patient reference (patid) that can be tied to patient information submitted to NCTN Navigator submissions.

Available Downloads: NCT00003088-D10

To gain access to the data and analytic tools click here.

Data Dictionary: NCT00003088-D10-Data-Dictionary.pdf

DATA: NCT00003088-D10-Dataset.csv

OTHER: README.pdf

Available Downloads: NCT00003088-D9

To gain access to the data and analytic tools click here.

Data Dictionary: NCT00003088-D9-Data-Dictionary.pdf

DATA: NCT00003088-D9-Dataset.csv

OTHER: README.pdf

Available Downloads: NCT00003088-D8

To gain access to the data and analytic tools click here.

Data Dictionary: NCT00003088-D8-Data-Dictionary.pdf

DATA: NCT00003088-D8-Dataset.csv

OTHER: README.pdf

Available Downloads: NCT00003088-D7

To gain access to the data and analytic tools click here.

Data Dictionary: NCT00003088-D7-Data-Dictionary.pdf

DATA: NCT00003088-D7-Dataset.csv

OTHER: README.pdf

Available Downloads: NCT00003088-D6

To gain access to the data and analytic tools click here.

Data Dictionary: NCT00003088-D6-Data-Dictionary.pdf

DATA: NCT00003088-D6-Dataset.csv

OTHER: README.pdf

Available Downloads: NCT00003088-D5

To gain access to the data and analytic tools click here.

Data Dictionary: NCT00003088-D5-Data-Dictionary.pdf

DATA: NCT00003088-D5-Dataset.csv

OTHER: README.pdf

Available Downloads: NCT00003088-D4

To gain access to the data and analytic tools click here.

Data Dictionary: NCT00003088-D4-Data-Dictionary.pdf

DATA: NCT00003088-D4-Dataset.csv

OTHER: README.pdf

Available Downloads: NCT00003088-D3

To gain access to the data and analytic tools click here.

Data Dictionary: NCT00003088-D3-Data-Dictionary.pdf

DATA: NCT00003088-D3-Dataset.csv

OTHER: README.pdf

Available Downloads: NCT00003088-D2

To gain access to the data and analytic tools click here.

Data Dictionary: NCT00003088-D2-Data-Dictionary.pdf

DATA: NCT00003088-D2-Dataset.csv

OTHER: README.pdf

Available Downloads: NCT00003088-D1

To gain access to the data and analytic tools click here.

Data Dictionary: NCT00003088-D1-Data-Dictionary.pdf

DATA: NCT00003088-D1-Dataset.csv

OTHER: README.pdf